Company Filing History:
Years Active: 2022-2025
Title: Lun Cui: Innovator in Antimicrobial Technologies
Introduction
Lun Cui is a prominent inventor based in Paris, France. She has made significant contributions to the field of antimicrobial technologies, particularly through her innovative approaches to DNA repair mechanisms in prokaryotic cells. With a total of two patents to her name, her work is paving the way for advancements in microbial resistance.
Latest Patents
Lun Cui's latest patents focus on sequence-specific antimicrobials that block DNA repair. The inventions aim to improve endonuclease-based antimicrobials by preventing the repair of double-strand breaks (DSBs) in prokaryotic cells. Specifically, her methods involve blocking DNA repair after a nucleic acid has been subjected to DSBs, utilizing a Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) associated programmable double-strand endonuclease. The patents also detail the use of exogenous molecules that inhibit DNA repair, particularly proteins that bind to the ends of the double-stranded break to obstruct DSB repair. Additionally, her inventions include vectors, such as phagemids and plasmids, that comprise nucleic acids encoding nucleases and Gam proteins, along with pharmaceutical compositions and products containing these vectors.
Career Highlights
Throughout her career, Lun Cui has worked with esteemed organizations, including the Institut Pasteur and Eligo Bioscience. Her experience in these institutions has allowed her to develop her innovative ideas and contribute to the scientific community significantly.
Collaborations
Lun Cui has collaborated with notable colleagues, including David Bikard and Xavier Duportet. These partnerships have further enhanced her research and development efforts in the field of antimicrobial technologies.
Conclusion
Lun Cui is a trailblazer in the realm of antimicrobial innovations, with her patents reflecting her commitment to advancing scientific knowledge and practical applications. Her work continues to inspire future research and development in the fight against microbial resistance.